Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (11-20 of 296) with videos related to

Pageof 30
Sort By:
Rheumatology (Oxford, England)|July 23, 2019
Adding value to real-world data: the role of biomarkersDarren Plant, Anne Barton
Discovery Medicine|September 30, 2010
The genetics of psoriatic arthritis: lessons from genome-wide association studiesJohn Bowes, Anne Barton
Seminars in Immunopathology|May 31, 2017
Genetics of rheumatoid arthritis susceptibility, severity, and treatment responseSebastien Viatte, Anne Barton
Current Rheumatology Reports|April 26, 2012
What have genome-wide studies told us about psoriatic arthritis?James Bluett, Anne Barton
Journal of Personalized Medicine|October 5, 2019
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid ArthritisBen Mulhearn, Anne Barton, Sebastien Viatte
Expert Review of Clinical Immunology|April 19, 2018
Prediction of response to methotrexate in rheumatoid arthritisStephanie Ling, James Bluett, Anne Barton
Pharmacogenomics|November 3, 2011
Genetic and genomic predictors of anti-TNF responseRita Prajapati, Darren Plant, Anne Barton
BMC Musculoskeletal Disorders|November 10, 2016
Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative studyKanta Kumar, Sarah Peters, Anne Barton, et al.
Current Opinion in Rheumatology|February 22, 2019
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?Meghna Jani, Anne Barton, Kimme Hyrich
Current Rheumatology Reports|May 19, 2015
Pharmacogenetics of treatment response in psoriatic arthritisMeghna Jani, Anne Barton, Pauline Ho
Pageof 30

Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
Rheumatology (Oxford, England)|July 23, 2019
Adding value to real-world data: the role of biomarkersDarren Plant, Anne Barton
Discovery Medicine|September 30, 2010
The genetics of psoriatic arthritis: lessons from genome-wide association studiesJohn Bowes, Anne Barton
Seminars in Immunopathology|May 31, 2017
Genetics of rheumatoid arthritis susceptibility, severity, and treatment responseSebastien Viatte, Anne Barton
Current Rheumatology Reports|April 26, 2012
What have genome-wide studies told us about psoriatic arthritis?James Bluett, Anne Barton
Journal of Personalized Medicine|October 5, 2019
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid ArthritisBen Mulhearn, Anne Barton, Sebastien Viatte
Expert Review of Clinical Immunology|April 19, 2018
Prediction of response to methotrexate in rheumatoid arthritisStephanie Ling, James Bluett, Anne Barton
Pharmacogenomics|November 3, 2011
Genetic and genomic predictors of anti-TNF responseRita Prajapati, Darren Plant, Anne Barton
BMC Musculoskeletal Disorders|November 10, 2016
Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative studyKanta Kumar, Sarah Peters, Anne Barton, et al.
Current Opinion in Rheumatology|February 22, 2019
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?Meghna Jani, Anne Barton, Kimme Hyrich
Current Rheumatology Reports|May 19, 2015
Pharmacogenetics of treatment response in psoriatic arthritisMeghna Jani, Anne Barton, Pauline Ho
Pageof 30